| Liver Transplantation for Unresectable GIST Liver Metastases (NCT04825470) | Hospital Universitario Virgen de la Arrixaca | 2022-05-01 |
| GPC3-Targeted T-Cell Therapy (ECT204) in Adults With Advanced HCC (NCT04864054) | Eureka Therapeutics Inc. | 2022-03-11 |
| Safety and Effectiveness of BioTraceIO Lite for Tissue Damage Assessment Following Liver Tissue Ablation Procedures (NCT04970212) | Techsomed Medical Technologies LTD | 2021-09-24 |
| Liver Transplantation in Patients With Unresectable Colorectal Liver Metastases (NCT04616495) | Hospital Universitario La Fe | 2021-09-01 |
| Study of ET140203 T Cells in Adults With Advanced Hepatocellular Carcinoma (ARYA-1) (NCT04502082) | Eureka Therapeutics Inc. | 2021-04-14 |
| DCE-CT of Thoracic Tumors as an Early Biomarker for Treatment Monitoring in Comparison With Morphologic Criteria (NCT04708483) | Hyperfusion | 2021-01-07 |
| Study of ET140202 T Cells in Adults With Advanced Hepatocellular Carcinoma (NCT03998033) | Eureka Therapeutics Inc. | 2019-05-30 |
| ET 140202 -T Cell Combined With TAE or Sorafenib in the Treatment of Liver Cancer (NCT03965546) | First Affiliated Hospital Xi'an Jiaotong University | 2019-05-30 |
| ET1402L1-ARTEMIS™2 T Cells in Alpha Fetoprotein (AFP) Expressing Hepatocellular Carcinoma (NCT03888859) | First Affiliated Hospital Xi'an Jiaotong University | 2017-12-06 |
| Clinical Study of ET1402L1-CAR T Cells in AFP Expressing Hepatocellular Carcinoma (NCT03349255) | Aeon Therapeutics (Shanghai) Co., Ltd. | 2017-10-06 |
| Improving CBCT for Liver IG-SBRT Using Gadoxetate Disodium (NCT03215355) | Slawa Cwajna | 2017-08-01 |
| Treat Primary and Metastatic Liver Tumors (NCT05240040) | Methodist Health System | 2016-04-26 |
| Prospective Tumor Response Evaluation (NCT02787954) | The University of Texas Health Science Center, Houston | 2016-01-01 |
| Reproducibility and Repeatability of Multifunctional MRI Biomarkers of the Body (NCT02201797) | Asan Medical Center | 2014-10-01 |
| Pilot Study of Irreversible Electroporation (IRE) to Treat Metastatic Liver Cancer & Cholangiocarcinoma (NCT01442324) | Azienda Ospedaliera di Padova | 2011-02-01 |
| Chemotherapy for Resectable Colorectal Liver Metastases (NCT04513457) | Fundación de Investigación Biomédica - Hospital Universitario de La Princesa | 2010-01-01 |
| Study Comparing Radio Frequency Ablation Plus Chemotherapy and Chemotherapy Alone in Patients With Secondary Liver Metastases (NCT00510627) | Boston Scientific Corporation | 2007-08-01 |
| Study of Capecitabine in Combination With SIR-Spheres in Patients With Advanced Cancer (NCT00604409) | Fox Chase Cancer Center | 2006-04-01 |
| Expanded Access Study of Melphalan With Delcath CS-PHP System in Patients With Ocular/Cutaneous Melanoma Mets to Liver (NCT01728051) | Delcath Systems Inc. | |